BIOMAT Database Logo BIOMAT Database Logo

Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. 1996

W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Departments of Neurological Surgery, robiolology, and Radiation Oncology, University of Southern California School of Medicine, Los Angeles, California 90033, USA.

Hypericin, an antidepressant and antiviral agent being evaluated in phase I and II trials for patients with HIV infection, is known to be a potent protein kinase C inhibitor. We have investigated its effects on cellular response to radiation via a tetrazolium-formazan cell growth rate assay using 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide and clonogenic assay in three human glioblastoma cell lines, U87-MG, A-172, and T98G, and a low-passage malignant glioma culture, 93-492. At a concentration of 5 microM, hypericin inhibited these cells slightly but caused significant radiosensitization (e.g., the cell survival rate after the radiation treatment was 50.2 and 26.0% in cells treated with 6 Gy and 6 Gy plus 5 microM hypericin in U87-MG cells, respectively; P = 0.0285). Hypericin also enhanced the radiosensitivity significantly in the low-passage glioma 93-492 cells. These findings suggest that hypericin represents a potential new agent in combination with radiation therapy of malignant gliomas.

UI MeSH Term Description Entries
D010569 Perylene A 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic. Perilene,Peri-Dinaphthalene,Peri Dinaphthalene
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Enhancement of radiosensitivity by tamoxifen in C6 glioma cells.
October 1992, Neurosurgery,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro.
February 2006, Journal of cancer research and clinical oncology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells.
January 2002, Journal of neuro-oncology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells.
August 1997, International journal of radiation biology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Properties of human malignant glioma cells in vitro.
August 1978, Medical biology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
April 2018, International journal of oncology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
March 2007, International journal of oncology,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.
November 1997, Cancer letters,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine.
January 1999, Neoplasma,
W Zhang, and L Anker, and R E Law, and D R Hinton, and R Gopalakrishna, and Q Pu, and U Gundimeda, and M H Weiss, and W T Couldwell
In vitro cellular radiosensitivity of human malignant melanoma.
July 1982, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!